Skip to main content

Table 3 Thirty-day mortality in Candida bloodstream infection. Multivariate analysis

From: Impact of inappropriate antifungal therapy according to current susceptibility breakpoints on Candida bloodstream infection mortality, a retrospective analysis

Characteristic

OR (95%CI)

OR (95%CI) without severe sepsis

Age

1.01 (0.98–1.03)

1.02 (0.99–1.05)

Inappropriate antifungal treatment a

0.16 (0.02–1.3)

0.1 (0.009–1.05)

Severe sepsis

3.5 (1.4–8.9)

Cirrhosis

42.1 (2.3–744)

56 (0.06–47,908)

Early CVC withdrawal

0.22 (0.07–0.63)

0.07 (0.017–0.28)

Empirical antifungal therapy

0.15 (0.03–0.62)

0.05 (0.005–0.55)

  1. OR Odds ratio; 95% CI: 95% confidence interval
  2. aAccording to CLSI 2012, CT Chemotherapy, CVC central venous catheter